diseases

HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus

HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus

HONG KONG, Oct 31, 2025 – (ACN Newswire) – HighTide Therapeutics, Inc. (2511.HK), a biopharmaceutical company specializing in the development of multifunctional, multi-targeted therapies for chronic...

CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Ra Humanized Monoclonal Antibody Injection MG-K10 Accepted in China

CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Ra Humanized Monoclonal Antibody Injection MG-K10 Accepted in China

SHENZHEN, Oct 30, 2025 – (ACN Newswire) – China Medical System Holdings Limited (“CMS”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an...

Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders

Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders

HONG KONG, Oct 30, 2025 – (ACN Newswire) – Everest Medicines (HKEX:1952.HK) today announced that it has acquired an exclusive license with Visara, Inc. (“Visara”),...

Can Passive Crypto Income Models Fund Public Health Research?

Can Passive Crypto Income Models Fund Public Health Research?

KEY TAKEAWAYS Passive crypto income models like staking, lending, and DAOs can generate continuous funding for public health research. Blockchain transparency ensures funds are traceable...

CMS (867.HK; 8A8.SG) Signed A Distribution Agreement for Ophthalmic Drugs Lucentis(R) and Beovu(R)

CMS (867.HK; 8A8.SG) Signed A Distribution Agreement for Ophthalmic Drugs Lucentis(R) and Beovu(R)

SHENZHEN, Oct 27, 2025 – (ACN Newswire) – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that on 27 October...

Health Canada Grants Authorization for "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease

Health Canada Grants Authorization for “LEQEMBI(R)” (lecanemab) for the Treatment of Early Alzheimer’s Disease

TOKYO and CAMBRIDGE, Mass., October 27, 2025 – (JCN Newswire) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB,...

FIG, Fujitsu, Acer Medical collaborate to develop health-promoting insurance concept to support preventative care in aging societies

FIG, Fujitsu, Acer Medical collaborate to develop health-promoting insurance concept to support preventative care in aging societies

Lausanne, Switzerland, Kawasaki, Japan, and New Taipei City, Taiwan, October 24, 2025 – (JCN Newswire) – The International Gymnastics Federation (FIG), the international governing body...

ChatGPT-Like AI Unveils 1,300 Regions in the Mouse Brain—Some Uncharted

ChatGPT-Like AI Unveils 1,300 Regions in the Mouse Brain—Some Uncharted

At the turn of the 20th century, Korbinian Brodmann released one of the most consequential brain maps ever. By studying the humps, grooves, layers, and...

A Nanoparticle Drug Triggered the Brain to Rapidly Flush Out Toxic Alzheimer’s Proteins in Mice

The brain is like a city within a fortress. Its cellular inhabitants normally hum along in their daily routines. Neurons send out the electrical signals...

WELCOME!

Please, verify your age to enter.

By entering this site, you are agreeing to the Terms of Use and Privacy Policy.